NASCAR Hall of Famer Dale Earnhardt Jr.'s decision came two days after Baltimore Ravens quarterback Lamar Jackson filed an ...

Jackson, who has worn No. 8 since his college days at Louisville, previously registered the trademark “ERA 8 by Lamar Jackson ...

Maryland-based ION Storage Systems is about to dramatically accelerate the commercialization of its unique solid-state ...

The settings on your phone can help you get better cell service, but there are other tricks for improving ... Keep holding it ...

Every second, an adult generates around five million new blood cells to replace aging or dying ones, making the blood system a highly regenerative organ. These new blood cells are formed in the ...

In a discovery with potential practical applications, a team of Rutgers biophysicists, bioengineers and plant biologists capture first live images In a groundbreaking study on the synthesis of ...

T1 Energy (NYSE: TE), formerly FREYR Battery, has revealed the location of its new US solar cell factory, set to be one of the largest in the country. The site, according to T1 Energy’s Q4 and ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For patients with severe corneal injuries, blindness has often been seen as a life ...

Alongside the ongoing straight up cash deals on the new M4 MacBook Air lineup, today we are turning our attention over to the iPads. Amazon has now dropped the prices even lower across most of the ...

COEP forms GEAR Therapeutics, as a majority-owned subsidiary, to advance GEAR-modified natural killer (NK) cells into first-in-human studies for broad range of cancers and other therapeutic ...

COEP forms GEAR Therapeutics, as a majority-owned subsidiary, to advance GEAR-modified natural killer (NK) cells into first-in-human studies for broad range of cancers and other therapeutic ...

YONGIN, South Korea, March 12, 2025 /PRNewswire/ -- GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for ...